Methotrexate Sodium Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Methotrexate Sodium Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on 03/13/2023.

Shortage Details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
63323-122-50
Dosage Form
Injection
Presentation
Methotrexate Preservative Free, Injection, 1 g (NDC 63323-122-50)
Initial Posting
03/13/2023
Revised Date